At Senolytic Therapeutics, we develop novel classes of medicines that target and eliminate damaged (senescent) cells.
Our mission is to advance our portfolio of therapies to clinical trials and improve the lives of those affected by diseases associated with aging.
We have developed a unique technological portfolio which is based on drug therapies that eliminate senescent in age-related diseases.
Senolytic Therapeutics is located in Boston (US) and Barcelona (Spain).
We are a member of the Life Biosciences group.